Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Caris Life Sciences,�Inc. (CAI) had Cash Flow from Financial Activities of $664.99M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$812.03M |
|
$-537.96M |
|
$272.87M |
|
$539.17M |
|
$766.92M |
|
$45.11M |
|
$-113.20M |
|
$-68.09M |
|
$-68.09M |
|
$-68.09M |
|
$-68.09M |
|
$-68.09M |
|
$-68.09M |
|
$45.11M |
|
$80.50M |
|
167.21M |
|
167.21M |
|
$-3.22 |
|
$-3.22 |
|
| Balance Sheet Financials | |
$997.80M |
|
$63.17M |
|
$127.86M |
|
$1.13B |
|
$127.14M |
|
$378.82M |
|
$421.21M |
|
$548.36M |
|
$577.31M |
|
$557.96M |
|
$577.31M |
|
282.53M |
|
| Cash Flow Statement Financials | |
$83.16M |
|
$-16.26M |
|
|
Cash Flow from Financial Activities |
$664.99M |
$68.03M |
|
$800.04M |
|
$732.01M |
|
$70.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
0.40 |
|
0.66 |
|
66.40% |
|
5.56% |
|
5.56% |
|
9.91% |
|
-8.38% |
|
-66.25% |
|
$66.89M |
|
-- |
|
-- |
|
-- |
|
0.72 |
|
4.29 |
|
7.24 |
|
50.41 |
|
-11.79% |
|
-12.20% |
|
-6.05% |
|
-7.12% |
|
$2.04 |
|
$0.40 |
|
$0.50 |
|